Quick Answer
INTEGRATED BIOPHARMA INC reported Cash And Cash Equivalents At Carrying Value of $3.62 million for the year ending 2025.
- INTEGRATED BIOPHARMA INC showed an increase of +115.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from INTEGRATED BIOPHARMA INC's annual report (Form 10-K), filed with the SEC on September 23, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2010: $347.0 thousand | Q1 2011: $772.0 thousand | Q3 2011: $931.0 thousand | Q4 2011: $447.0 thousand | Q1 2012: $649.0 thousand | Q3 2012: $216.0 thousand | Q4 2012: $124.0 thousand | Q1 2013: $285.0 thousand | Q3 2013: $480.0 thousand | Q4 2013: $135.0 thousand | Q1 2014: $184.0 thousand | Q2 2014: $451.0 thousand | Q3 2014: $294.0 thousand | Q4 2014: $48.0 thousand | Q1 2015: $354.0 thousand | Q3 2015: $84.0 thousand | Q4 2015: $60.0 thousand | Q1 2016: $450.0 thousand | Q3 2016: $92.0 thousand | Q4 2016: $66.0 thousand | Q1 2017: $196.0 thousand | Q3 2017: $284.0 thousand | Q4 2017: $54.0 thousand | Q1 2018: $62.0 thousand | Q2 2018: $228.0 thousand | Q3 2018: $365.0 thousand | Q4 2018: $45.0 thousand | Q1 2019: $431.0 thousand | Q3 2019: $525.0 thousand | Q4 2019: $67.0 thousand | Q1 2020: $565.0 thousand | Q3 2020: $369.0 thousand | Q4 2020: $43.0 thousand | Q1 2021: $105.0 thousand | Q3 2021: $57.0 thousand | Q4 2021: $162.0 thousand | Q1 2022: $264.0 thousand | Q3 2022: $1.17 million | Q4 2022: $1.09 million | Q1 2023: $2.53 million | Q3 2023: $2.59 million | Q4 2023: $732.0 thousand | Q1 2024: $2.02 million | Q3 2024: $2.27 million | Q4 2024: $2.46 million | Q1 2025: $2.96 million | Q2 2025: $3.62 million | Q3 2025: $4.73 million | Q4 2025: $5.31 million.
- Over the full 16 years of available data (2010 to 2025), INTEGRATED BIOPHARMA INC's Cash And Cash Equivalents At Carrying Value has grown by 458.7%.
- Historical annual values: Fiscal year 2025: $3.62 million | Fiscal year 2024: $1.68 million | Fiscal year 2023: $1.32 million | Fiscal year 2022: $331.0 thousand | Fiscal year 2021: $210.0 thousand | Fiscal year 2020: $402.0 thousand | Fiscal year 2019: $475.0 thousand | Fiscal year 2018: $228.0 thousand | Fiscal year 2017: $132.0 thousand | Fiscal year 2016: $395.0 thousand | Fiscal year 2015: $71.0 thousand | Fiscal year 2014: $451.0 thousand | Fiscal year 2013: $55.0 thousand | Fiscal year 2012: $145.0 thousand | Fiscal year 2011: $725.0 thousand | Fiscal year 2010: $647.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: